BrightGene Bio (China) Price on November 29, 2024
| 688166 Stock | 29.55 0.68 2.36% |
Below is the normalized historical share price chart for BrightGene Bio Medical extending back to November 08, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of BrightGene Bio stands at 29.55, as last reported on the 15th of January 2025, with the highest price reaching 29.68 and the lowest price hitting 28.72 during the day.
If you're considering investing in BrightGene Stock, it is important to understand the factors that can impact its price. At this point, BrightGene Bio is not too volatile. BrightGene Bio Medical secures Sharpe Ratio (or Efficiency) of 0.0029, which signifies that the company had a 0.0029% return per unit of risk over the last 3 months. We have found twenty-two technical indicators for BrightGene Bio Medical, which you can use to evaluate the volatility of the firm. Please confirm BrightGene Bio's Mean Deviation of 2.6, risk adjusted performance of (0.01), and Standard Deviation of 3.74 to double-check if the risk estimate we provide is consistent with the expected return of 0.0107%.
The current year's Other Stockholder Equity is expected to grow to about 21.5 M, whereas Total Stockholder Equity is forecasted to decline to about 1.4 B. . BrightGene Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
200 Day MA 30.7918 | 50 Day MA 31.5174 | Beta 0.386 |
BrightGene |
Sharpe Ratio = 0.0029
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 688166 |
Estimated Market Risk
| 3.72 actual daily | 33 67% of assets are more volatile |
Expected Return
| 0.01 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average BrightGene Bio is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BrightGene Bio by adding BrightGene Bio to a well-diversified portfolio.
Price Book 5.1848 | Enterprise Value Ebitda 66.0775 | Price Sales 10.0354 | Shares Float 259.2 M | Wall Street Target Price 44.21 |
BrightGene Bio Valuation on November 29, 2024
It is possible to determine the worth of BrightGene Bio on a given historical date. On November 29, 2024 BrightGene was worth 31.39 at the beginning of the trading date compared to the closed value of 31.96. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of BrightGene Bio stock. Still, in general, we apply an absolute valuation method to find BrightGene Bio's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of BrightGene Bio where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against BrightGene Bio's related companies.
| Open | High | Low | Close | Volume | |
| 32.30 | 32.30 | 31.30 | 31.60 | 6,503,778 | |
11/29/2024 | 31.39 | 32.35 | 31.08 | 31.96 | 9,138,894 |
| 31.80 | 32.55 | 31.52 | 32.35 | 9,964,512 |
| Backtest BrightGene Bio | | | BrightGene Bio History | | | BrightGene Bio Valuation | Previous | Next |
BrightGene Bio Trading Date Momentum on November 29, 2024
| On December 02 2024 BrightGene Bio Medical was traded for 32.35 at the closing time. The highest price during the trading period was 32.55 and the lowest recorded bid was listed for 31.52 . The volume for the day was 10 M. This history from December 2, 2024 contributed to the next trading day price jump. The daily price change to the next closing price was 1.22% . The overall trading delta to the current price is 2.72% . |
BrightGene Bio Medical Fundamentals Correlations and Trends
By evaluating BrightGene Bio's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among BrightGene Bio's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. BrightGene financial account trend analysis is a perfect complement when working with valuation or volatility modules.About BrightGene Bio Stock history
BrightGene Bio investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for BrightGene is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in BrightGene Bio Medical will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing BrightGene Bio stock prices may prove useful in developing a viable investing in BrightGene Bio
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 485.8 M | 340.7 M | |
| Net Income Applicable To Common Shares | 275.6 M | 141.5 M |
BrightGene Bio Quarterly Net Working Capital |
|
BrightGene Bio Stock Technical Analysis
BrightGene Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
BrightGene Bio Period Price Range
Low | January 15, 2025
| High |
0.00 | 0.00 |
BrightGene Bio Medical cannot be verified against its exchange. Please verify the symbol is currently traded on Shanghai Stock Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
BrightGene Bio January 15, 2025 Market Strength
Market strength indicators help investors to evaluate how BrightGene Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading BrightGene Bio shares will generate the highest return on investment. By undertsting and applying BrightGene Bio stock market strength indicators, traders can identify BrightGene Bio Medical entry and exit signals to maximize returns
BrightGene Bio Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for BrightGene Bio's price direction in advance. Along with the technical and fundamental analysis of BrightGene Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of BrightGene to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.09) | |||
| Total Risk Alpha | (0.03) | |||
| Treynor Ratio | (0.28) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for BrightGene Stock analysis
When running BrightGene Bio's price analysis, check to measure BrightGene Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BrightGene Bio is operating at the current time. Most of BrightGene Bio's value examination focuses on studying past and present price action to predict the probability of BrightGene Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BrightGene Bio's price. Additionally, you may evaluate how the addition of BrightGene Bio to your portfolios can decrease your overall portfolio volatility.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |